Approval of Drug Tracking system to track the progress in Patients
The US Department of Health and Human Services Food and Drug Administration (FDA) broke the shackles on the improvement of facilitative drug that can cure endemic diseases. The US regulator gave away the green signal to one of the first drugs to have sensor in order to alert the doctors when the medication has been taken off. The regulators while approving the tests of the drugs also raised privacy and security concerns that come with it, the concerns raised by many and debated upon various media platforms the entire month.
The Pill which was approved by the FDA is a combination of the two sideways technologies namely – the blockbuster psychiatric medication Abilify which has long been used as a treatment to schizophrenia and bipolar disorders with a tracking device by developed and approved in the year 2012. The combination can be helpful in tracking the medication impact on the Patients and simultaneously let the doctors know when or if the medication has been taken off.
Often patients with schizophrenia or bipolar disorder risk their lives by skipping or laying off their prescribed medications thereby putting themselves in simulated dangers while themselves being unknown to such circumstances. This combination will then help to restore the medication through alert sent to the doctors and can be monitored.
The Concern with the combination
The developers of the combination – Otsuka Pharmaceutical Company and Proteus Digital Health have their own concerns to deal with its layout. Some of the concerns listed can be –
No Proper Impact
The developers of the combination have by now failed to convince the general mass the impact of the drug and its compliances. The patients compliance to the combination will not often produce results as the company has offered and sometimes it might hurt the regulators on their decision of approval.
The utmost cynical criticism of the drug is based on the concerns of Privacy on it. as per the concerns noted, the tracking can often be deterred with breach of medical data or say unauthorised surveillance of some sorts. It is commonly fancies amongst the masses that the drug might be used by the NSA or the FBI or agencies to track the movements of the people. Well, the espionage based movies can be blamed for that sort of thinking.
On Ethical grounds
The elderly mass in the US feel that the drug with a chip in it might be unethical to use a chip in a drug. "It's truth serum time," said Arthur Caplan, a medical ethicist at NYU's Langone Medical Center. "Is the doctor going to start yelling at me? Am I going to get a big accusatory speech? How will that interaction be handled?"
How does the Ambilify MyCite Work in real time?
It is imperative to know how the Ambilify MyCite works in real time in order to track all the laxities which come with it. lets check out –
Ambilify MyCite can be termed as a medical chiplet embedded with the Ambilify medicare. It is a tiny chip roughly of the size of a granule of sand embedded with the medicine. It is then swallowed by the patients. It then hits the stomach walls and signal is beamed up to a patch on the affected person’s skin. The signal is then send to the receiving port which indicates that the medication has been taken. This mechanism also addresses the concerns often raised by the doctors about the intake of the medication. Often people do not take the medication in the fashion prescribed by the doctors and hence this can be a relief to them.
As per the FDA, who also addressed the concerns of Privacy by the critics by saying that – the documentation and monitoring can only be done if permitted by the Patient in writing while the developers said "with the patient's consent, this information could be shared with their health care professional team and selected family and friends, with the goal of allowing physicians to be more informed in making treatment decisions that are specific to the patient's needs."
This is a huge step forward for the medical fraternity which sees the amalgamation of technology with medicare. The FDA therefore have taken a progressive stance which when analysed with no speculative lenses can be answers to long questions.